Literature DB >> 9648706

Identification of IL-16 as the lymphocyte chemotactic activity in the bronchoalveolar lavage fluid of histamine-challenged asthmatic patients.

M V Mashikian1, R E Tarpy, J J Saukkonen, K G Lim, G D Fine, W W Cruikshank, D M Center.   

Abstract

OBJECTIVE: We have previously demonstrated that the earliest lymphocyte chemotactic factors present in bronchoalveolar lavage fluid (BALF) of subjects with atopic asthma after subsegmental antigen challenge are IL-16 and MIP-1alpha, of which IL-16 appears to contribute a majority of the chemotactic activity. Because IL-16 is released in vitro after histamine stimulation of CD8+ T cells and epithelial cells, we evaluated the potential role of histamine in the release of IL-16 into the airways of allergic asthmatics in vivo.
METHODS: Eight allergic asthmatic subjects, six normal subjects, and six atopic nonasthmatic subjects were challenged with saline in the lingula and with serial concentrations of histamine (1 x 10(-7) to 5 x 10(-5) mol/L) in the right middle lobe followed by bronchoalveolar lavage (BAL) 15 minutes and 6 hours later.
RESULTS: The BALF from saline- and histamine-challenged lobes of normal subjects and atopic nonasthmatic subjects contained no significant lymphocyte chemoattractant activity. In six of the eight atopic asthmatic subjects, the histamine-challenged but not saline-challenged segment contained IL-16 chemotactic activity but no other identifiable lymphocyte chemoattractant activities at 6 hours.
CONCLUSIONS: IL-16 appears in the airways after histamine challenge and therefore could contribute to the earliest infiltration of CD4+ T cells and eosinophils observed after antigen challenge due to histamine release from mast cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9648706     DOI: 10.1016/s0091-6749(98)70403-8

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes.

Authors:  N L Mathy; W Scheuer; M Lanzendörfer; K Honold; D Ambrosius; S Norley; R Kurth
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

3.  Interleukin-16 aggravates ovalbumin-induced allergic inflammation by enhancing Th2 and Th17 cytokine production in a mouse model.

Authors:  Chunxia Li; Jun Dai; Guanjun Dong; Qun Ma; Zhihua Li; Hui Zhang; Fenglian Yan; Junfeng Zhang; Bo Wang; Hui Shi; Yuzhen Zhu; Xiaoying Yao; Chuanping Si; Huabao Xiong
Journal:  Immunology       Date:  2019-07       Impact factor: 7.397

Review 4.  Rhinoviruses in the pathogenesis of asthma.

Authors:  Nikolaos G Papadopoulos; Stelios Psarras
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

5.  pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis.

Authors:  Suzanne Kafaja; Isela Valera; Anagha A Divekar; Rajan Saggar; Fereidoun Abtin; Daniel E Furst; Dinesh Khanna; Ram Raj Singh
Journal:  JCI Insight       Date:  2018-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.